Antibody_ID,Target_Epitope,Priority,Timeline,Clinical_Potential,Estimated_Discovery_Cost,Estimated_Optimization_Cost\nAB_0001,LLDDKFVLL,HIGH_PRIORITY,Fast_track_6_12_months,Phase_I_ready,$50K - $100K,$200K - $500K\nAB_0002,ILPTMIRLL,HIGH_PRIORITY,Fast_track_6_12_months,Phase_I_ready,$50K - $100K,$200K - $500K\nAB_0003,LLGRPHVKL,HIGH_PRIORITY,Fast_track_6_12_months,Phase_I_ready,$50K - $100K,$200K - $500K\nAB_0004,PVKASTGTL,HIGH_PRIORITY,Fast_track_6_12_months,Phase_I_ready,$50K - $100K,$200K - $500K\nAB_0005,ALLPTWIIL,HIGH_PRIORITY,Fast_track_6_12_months,Phase_I_ready,$50K - $100K,$200K - $500K\nAB_0006,EVTGYILPV,HIGH_PRIORITY,Fast_track_6_12_months,Phase_I_ready,$50K - $100K,$200K - $500K\nAB_0007,TLTSYLTAI,HIGH_PRIORITY,Fast_track_6_12_months,Phase_I_ready,$50K - $100K,$200K - $500K\nAB_0008,PMEVTGYIL,HIGH_PRIORITY,Fast_track_6_12_months,Phase_I_ready,$50K - $100K,$200K - $500K\nAB_0009,QLALKGRIL,HIGH_PRIORITY,Fast_track_6_12_months,Phase_I_ready,$50K - $100K,$200K - $500K\nAB_0010,VLLSRAGQL,HIGH_PRIORITY,Fast_track_6_12_months,Phase_I_ready,$50K - $100K,$200K - $500K\nAB_0011,RILPTMIRL,HIGH_PRIORITY,Fast_track_6_12_months,Phase_I_ready,$50K - $100K,$200K - $500K\nAB_0012,DLLDDKFVL,HIGH_PRIORITY,Fast_track_6_12_months,Phase_I_ready,$50K - $100K,$200K - $500K\nAB_0013,SALLPTWII,HIGH_PRIORITY,Fast_track_6_12_months,Phase_I_ready,$50K - $100K,$200K - $500K\nAB_0014,YILPVKAST,HIGH_PRIORITY,Fast_track_6_12_months,Phase_I_ready,$50K - $100K,$200K - $500K\nAB_0015,LSRAGQLAL,HIGH_PRIORITY,Fast_track_6_12_months,Phase_I_ready,$50K - $100K,$200K - $500K\n